Loss of T-cell receptor-CD3ζ and T-cell function in tumor-infiltrating lymphocytes but not in tumor-associated lymphocytes in ovarian carcinoma

Surgery

Volumn 129, Issue 6, 2001, Pages 749-756

  Lockhart, Diane C ^a,b   Chan, Allen K ^a,b   Mak, Simona ^a,b   Joo, Hong Gu ^a,b   Daust, Heather A ^a,b   Carritte, Amanda ^a,b   Douville, Cara C ^a,b   Goedegebuure, Peter S ^a,b   Eberlein, Timothy J ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; HYDROGEN PEROXIDE; INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MACROPHAGE; OVARY CARCINOMA; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TUMOR ASSOCIATED LEUKOCYTE; WESTERN BLOTTING;

EID: 0035001968     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2001.114554     Document Type: Article

References (32)

1. New subunit of the human T-cell antigen receptor complex
2. Signal transduction events leading to T-cell lymphokine gene expression
3. Alterations in T cells of cancer-bearers: Whence specificity?
4. Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice
5. Preventing abnormalities in signal transduction of T cells in cancer: The promise of cytokine gene therapy
6. Decreased expression of the signal-transducing ζ chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma
7. Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell- and natural killer cell-mediated cytotoxicity
8. Activated macrophages induce structural abnormalities of the T cell receptor-CD3 complex
9. Tumor-induced suppression of T lymphocyte proliferation coincides with inhibition of Jak3 expression and IL-2 receptor signaling
10. Pancreatic cancer cells can evade immune surveillance via nonfunctional Fas (APO-1/CD95) receptors and aberrant expression of functional Fas ligand
11. The Fas counterattack: Cancer as a site of immune privilege
12. Caspase-mediated degradation of T-cell receptor ζ-chain
13. T cell recognition of ovarian cancer
14. Human tumor-infiltrating CD4+ T cells react to B cell lines expressing heat shock protein 70
15. T-cell receptor ζ-chain expression on tumor-infiltrating lymphocytes from renal cell carcinoma
16. Monoclonal antibodies reactive with the T cell receptor ζ chain: Production and characterization using a new method
17. Immunosuppression and transforming growth factor-β in glioblastoma: Preferential production of transforming growth factor-β
18. Immunosuppressive factors: Role in cancer development and progression
19. Soluble MUC1 secreted by human epithelial cancer cells mediates immune suppression by blocking T-cell activation
20. Detection of soluble adhesion molecules in pleural effusions
21. Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: Effects of tumor cells and their supernatants on proliferative responses of lymphocytes
22. Proliferative and cytolytic potentials of purified human tumor-infiltrating T lymphocytes. Impaired response to mitogen-driven stimulation despite T-cell receptor expression
23. Vaccination with IL-2-secreting tumor cells stimulates the generation of IL-2 responsive T cells and prevents the development of unresponsiveness
24. CTLA-4 blockade reverses CD8+ T cell tolerance to tumor by a CD4+ T cell- and IL-2-dependent mechanism
25. Lymphocyte apoptosis induced by Fas ligand-expressing ovarian carcinoma cells
26. Conversion of membrane-bound Fas (CD95) ligand to its soluble form is associated with down-regulation of its proapoptotic activity and loss of liver toxicity
27. Differential activity of soluble versus cellular Fas ligand: Regulation by an accessory molecule
28. Tumor gangliosides inhibit the tumor-specific immune response
29. Downregulation of JAK3 protein levels in T lymphocytes by prostaglandin E2 and other cyclic adenosine monophosphate-elevating agents: Impact on interleukin-2 receptor signaling pathway
30. Treatment with anti-Fas ligand antibody eliminates immunosuppression by Lewis lung carcinoma cells through Fas ligand
31. Abnormal signal transduction by T cells of mice with parental tumors is not seen in mice bearing IL-2-secreting tumors
32. Alterations in NFkB/Rel family proteins in splenic T-cells from tumor-bearing mice and reversal following therapy